Unique Ingredient Identifier K0KQV10C35 is listed as a ingredient substance
| RN | 9003-39-8 |
| NCIT | C82259 |
| RXCUI | 1367141 |
| MF | Polymer substance not supported |
UNII K0KQV10C35 POVIDONE K25 is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| ORAL | CAPSULE | 30 mg |
| ORAL | CAPSULE, EXTENDED RELEASE | 21.36 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 17.79 MG |
| ORAL | CAPSULE, SUSTAINED ACTION, HARD GELATIN | 12.6 MG |
| ORAL | GRANULE, FOR ORAL SUSPENSION | 0.27 MG |
| ORAL | SOLUTION | 500 MG/5ML |
| ORAL | SUSPENSION, SUSTAINED ACTION | 0.27 MG/206.84 MG |
| ORAL | TABLET | 52 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 54.47 MG |
| ORAL | TABLET, CHEWABLE | 0.45 MG |
| ORAL | TABLET, COATED | 40 MG |
| ORAL | TABLET, DELAYED ACTION | 12.3 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 20 MG |
| ORAL | TABLET, EXTENDED RELEASE | 5 MG |
| ORAL | TABLET, FILM COATED | 22.5 MG |
| ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 1.8 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | NA |